Morningstar Rating

Stock Research and Analysis

by Matthew Coffina
WellPoint's unmatched regional scale provides the company with significant cost advantages and reliable free cash flows. With the threat of major health-care reform diminishing and underwriting results improving, we are enthusiastic about WellPoint's   Read more 

Bulls Say

WellPoint has the largest medical membership among health insurers, giving it significant bargaining power with health-care providers and leveraging its largely fixed cost structure.
We think the market has overreacted to the threat posed by reform legislation. Even if reform were to pass in its current form, we think the impact on WellPoint would be modest.
Some proposed health-care reforms would be a net positive for WellPoint. The company is strong in the individual and small-group market, and it could gain customers as efforts are made to reduce the number of uninsured Americans.
WellPoint enjoys the best-known and most-trusted brand name in the business. It is the exclusive licensee of the Blue Cross and/or Blue Shield brands in 14 states.
Unlike its peers in other states, WellPoint generally doesn't have to compete with nonprofit Blue Cross and Blue Shield plans. Read more 

Bears Say

President Obama and the Democrat-dominated Congress are looking to enact major health-care policy reform. Some reform proposals could have a significant negative effect on WellPoint's business.
Medicare controls over $450 billion of health-care spending, giving it better administrative cost leverage and much lower provider rates than any private MCO. If a new public insurance program were created with rates linked to Medicare, it would have significant competitive advantages.
Some of WellPoint's peers are still recovering from 2008's underwriting missteps. If WellPoint doesn't recognize future shifts in medical cost trends and change prices accordingly, the effect on earnings can be drastic.
Rising unemployment results in a smaller market for employer-based insurance, and fewer members can result in deleveraging of WellPoint's fixed costs.
WellPoint's $23 billion investment portfolio could lose value if financial markets decline. Read more 

Strategy

WellPoint has refocused its attention on the core medical benefits business, having sold its pharmacy benefit management business to Express Scripts ESRX. Most of the company's sizeable free cash flow   Read more 

Management

We are cutting WellPoint's stewardship grade to reflect an average rating. While we have been impressed by the speed with which management recognized and reacted to accelerating medical costs in 2008, we are disappointed by how poorly the company has   Read more 

Profile

WellPoint is the largest U.S. health insurer by medical membership, serving 34 million people. It holds the exclusive license to the Blue Cross and/or Blue Shield names   Read more 

First Name
Last Name
Email Address
Zip Code
Create Password
Verify Password
(6-15 characters; case sensitive)

Did Health-Care Reform Die in Massachusetts? 
Watch more 

View all of our analyst reports with a free trial to Morningstar.com Premium.